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Ibuprofen Transport into and through Skin from
Topical Formulations: In Vitro –In Vivo Comparison
Christophe Herkenne1,2, Aarti Naik1,2, Yogeshvar N. Kalia1,2, Jonathan Hadgraft3 and Richard H. Guy1,4
The goal was to compare ibuprofen transport into and through skin in vivo in man and in vitro (across silicone
membranes and freshly excised pig skin) from four marketed formulations. Ibuprofen gels were administered in
vivo for 30 minutes. The stratum corneum (SC) at the application site was then tape-stripped, quantified
gravimetrically, and extracted for drug analysis. Together with concomitant transepidermal water loss
measurements, SC drug concentration-depth profiles were reproducibly determined and fitted mathematically
to obtain a partition coefficient, a first-order rate constant related to ibuprofen diffusivity, and the total drug
amount in the SC at the end of the application. All derived parameters were consistent across formulations.
Ibuprofen permeation data through both silicone membrane and pig ear skin were also fitted to yield
partitioning and diffusion parameters. The former revealed that ibuprofen partitioned differently from the gels
into this model barrier. Across pig skin, however, better correlation with in vivo results was found. The derma-
topharmacokinetic approach, using SC tape-stripping, offers a valid method to assess equivalency between
topical drug formulations. In vitro experiments must be extrapolated cautiously to the clinic, especially when
complex interactions between real formulations, which deliver both drug and excipients, and the skin occur.
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INTRODUCTION
The penetration of a drug through the skin is a complex
process typically rate-limited by the stratum corneum (SC).
This external layer of the skin is composed of terminally
differentiated corneocytes embedded in a complex lipid
matrix comprising primarily ceramides, cholesterol, and free
fatty acids (Elias, 1983; Wertz et al., 1989; Wertz, 2000). Not
surprisingly, therefore, the SC presents a considerable barrier
to the transport of hydrophilic substances (including water,
of course). On the other hand, the viable epidermis, situated
below the SC, is much more aqueous in nature and only
contributes significantly to barrier function for very lipophilic
substances. Ibuprofen is a small molecule (MW 206) with
a log (octanol–water partition coefficient (P)) of around 4, and
is used topically to treat local inflammation with a site of
action clearly beneath the transport-limiting barriers of the
skin. Delivery of this drug by passive diffusion and the
pharmacological effect elicited are dose-related: the better
the drug permeates the skin, the greater the therapeutic
effect. It follows, therefore, that formulation plays an
important role in topical drug delivery as the composition
of the vehicle will influence the partitioning and/or the
diffusivity of the drug and hence the absolute amount
delivered. In vitro experiments, using either artificial
membranes or excised skin (from humans or an animal
model), are frequently employed to screen and optimize
topical formulations; direct correlation of the results of these
experiments with in vivo performance (with the exception of
limited examples using clinical trials or indirect pharmaco-
dynamic assays) are less frequently undertaken. The goal of
this study, then, was to compare ibuprofen transport into and
through skin in vivo an in vitro from four commercially
available gels that are currently marketed in Europe for the
same therapeutic indications.
RESULTS AND DISCUSSION
In vivo results
Figure 1 compares the concentration profiles of ibuprofen
across the SC in four volunteers following delivery of the
drug from four different gels after a 30-minute application.
The lines drawn through the data represent the best fits of
Eq. (1) to each set of results. The absolute amount of drug (in
moles) on each tape-strip was determined by HPLC, and
the weight of SC removed on a tape-strip divided by the
density of the tissue yielded a value of the volume, there-
by permitting the drug concentration to be expressed in
molar (M or mol dm3) units as shown. Determination of the
normalized SC depth (x/L) is described in Materials and
Methods. It is worth noting at the outset that the inter-subject
variability is rather low, suggesting that the methodology is
robust. Second, it is clear that the gels do not deliver
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ibuprofen identically into the skin, with Artofen and Optifen
resulting in higher levels of drug in the outer SC whereas
Brufen and Iprogel allow deeper penetration into the barrier.
The details behind this differential delivery of ibuprofen
are revealed by the analysis of the concentration profiles
using Eq. (1). The resulting values of K (the SC–vehicle
partition coefficient of ibuprofen) and D/L2 are summarized
in Table 1. Although there are statistically significant
differences between the partition coefficients deduced for
the different gels, overall the values of K for the four
formulations are quite consistent (varying by less than a
factor of 2.5). The partition coefficient is related to the y-axis
intercept of the profiles in Figure 1 via the drug concentration
in the vehicle. Hence, the fact that Artofen and Brufen have
identical K, whereas the concentration profiles of the former
result in a 2-fold higher intercept than those of the latter, is a
direct reflection of the fact that ibuprofen is present at 10% in
Artofen and 5% in Brufen. The partition coefficient of
ibuprofen between the SC and Optifen is the highest. This
means that either the drug’s affinity for this gel is significantly
less than for the others (i.e., its thermodynamic activity, or
leaving tendency, is greater) or that one or more excipients
from this formulation enter the SC and increase the drug’s
solubility therein. In the absence of detailed information
about the composition of the gels, however, or direct
quantification of other components of the vehicle in the SC,
the precise explanation cannot be deduced.
The diffusivity, or kinetic parameter (D/L2), also reveals
some differences (albeit by no more than 3-fold) between
formulations. As all four gels were tested on the same four
volunteers, these differences are attributable to differences in
diffusivity rather than SC thickness (12.671.1 mm). A classic
diffusion lag time (L2/6D) can be deduced from these values
and varies from about 45 minutes for Brufen and Iprogel to
more than 2 hours for Optifen; this means that whereas it
would take only 2 hours to reach steady-state transport for the
gels with the larger kinetic parameters, the others would
need on the order of 5 hours. Again, the exact mechanism
underlying the differences cannot be identified although
the known presence of isopropanol in Brufen (information
provided to the consumer with the product) may be
implicated in the higher drug diffusivity deduced for
ibuprofen when delivered from this gel.
Differences in the values of K and D/L2 are somewhat
‘‘damped’’ when used to calculate the theoretical drug
permeability coefficients (Kp¼K(D/L2)L) and steady-state
fluxes (JSS¼KpCv), which differ by no more than a factor of
two (Table 1). Nevertheless, a one-way analysis of variance
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Figure 1. Ibuprofen concentration profiles across SC in vivo. In vivo concentration versus normalized SC depth (x/L) profiles of ibuprofen following 30 minutes
treatment with Artofen, Brufen, Iprogel, and Optifen gels.
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clearly shows that Brufen confers the highest permeability
coefficient on ibuprofen. It should be pointed out that steady-
state conditions are rarely attained in the real world following
topical drug application. Typical scenarios include evapora-
tion of components of the formulation and at least partial
removal via contact with clothes, etc, to leave a dry residue.
Additional factors, such as the dosing regimen, and the
strength and duration with which the vehicle is rubbed into
the skin, will further complicate the situation. The shorter
application time used here is probably more realistic for a
topical non-steroidal anti-inflammatory drug application.
One-way analysis of variance (Po0.05) shows that Artofen
delivers significantly more drug into the SC compared to the
three other formulations, while Iprogel is the least efficient
formulation. Brufen and Optifen deliver similar, intermediate
amounts of ibuprofen.
Whether these differences in area under the curve trans-
late into clinically significant outcomes is unlikely unless
the levels eventually penetrating to the site of action fall
on a particularly sensitive part of the dose–response curve.
The fact that these commercial products are all available
without prescription, and are used interchangeably, suggests
that this is not the case.
In vitro results
Silicone membrane. Figure 2 shows that very different
permeation rates of ibuprofen through silicone membrane
were obtained. The nearly 50-fold range in flux between
Iprogel and Artofen, while partly due to a higher drug
diffusivity, was primarily the result of much more efficient
partitioning of the drug from the former gel (Table 2).
It was observed with Iprogel, after about 3 hours of
permeation, that drug precipitation occurred at the interface
of the formulation with the silicone membrane. It was
postulated that the ‘‘back diffusion’’ of water from the
receiver compartment into the gel lowered the solubility of
the drug in the formulation resulting ultimately in ibuprofen
coming out of solution (i.e., its degree of saturation reached a
value of unity). This idea was confirmed by measuring
transepidermal water loss (TEWL) (with the standard evapori-
meter used in the in vivo experiments described previously)
with the probe positioned in the donor compartment above
the polymeric membrane; it was found that the outward
water flux was approximately 15% of that measured when
the membrane was absent – that is, a substantial flow of
solvent. The presence of the gel, in fact, may further
increase this value owing to the hygroscopic effect of the
propylene glycol present in the Iprogel formulation (informa-
tion provided to the consumer with the product); in any
case, the deduced values of the transport parameters
Table 1. Transport parameters of ibuprofen across SC following topical drug delivery from four gels
(mean7SD, n=4)
Formulation1 K2,3 D/L2 (h1)2,4 AUC (M)5,6 Amount in SC (lg)7 103Kp8,9 (cm/h) Jss10,11 (lg cm2 h1)
ARTOFEN 3.1670.19 0.09570.020 0.37470.035 482719 0.3770.04 37.173.7
BRUFEN 3.1170.26 0.21170.054 0.26470.021 343747 0.8170.19 40.779.7
IPROGEL 1.9270.21 0.21170.055 0.16370.018 212734 0.5170.14 25.477.2
OPTIFEN 4.8070.47 0.07270.022 0.24770.051 317747 0.4370.13 21.476.4
AUC, area under the curve; ANOVA, analysis of variance; SC, stratum corneum; SD, standard deviation; TEWL, transepidermal water loss.
1Ibuprofen concentration in Artofen was 10% w/w; in the other gels, the drug was present at 5%.
2Values from the best-fits of Eq. (1) to the results in Figure 1.
3One-way ANOVA indicates no difference (P40.05) between the values for Artofen and Brufen. All other values were significantly different (Po0.05) from
one another.
4One-way ANOVA indicates that the values for Artofen and Optifen, and for Brufen and Iprogel, were similar. All other pairings differed significantly
(Po0.05).
5Values determined by integration of Eq. (1) from x=0 to x=L (Eq. (2)) using the corresponding fitted parameters for D/L2 and K for each subject.
6One-way ANOVA indicates that all AUCs were significantly different (Po0.05) from one another except those for Brufen and Optifen, which were not.
7Values determined by multiplying the AUC by the area of SC exposed and by the apparent thickness (L) of the SC for each subject.
8The permeability coefficient, Kp=K(D/L
2)L; K and D/L2 were from the fitting procedure, whereas L was determined experimentally for each subject (via
TEWL measurements).
9One-way ANOVA shows that significant differences (Po0.05) were found between Artofen and Brufen, Brufen and Iprogel, and Brufen and Optifen.
10The steady-state flux (Jss)=KpCv.
11One-way ANOVA indicates that significant differences (Po0.05) existed between Artofen and Optifen, Brufen and Iprogel, and Brufen and Optifen.
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Figure 2. Ibuprofen transport across a silicone membrane in vitro.
Steady-state flux of ibuprofen through a silicone membrane of 120 mm
thickness (mean7SD, n¼ 4).
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reported above may only be considered approximate given
the evidently changing drug thermodynamic activity during
the experiment.
Pig ear skin. The cumulative permeation of ibuprofen
from the four gels through dermatomed (750 mm) pig
ear skin is shown in Figure 3. The experimental data
were fitted to Eq. (3) to obtain the partition (KL) and diffusion
(D/L2) parameters. The measured fluxes and permeability
coefficients for Brufen and Iprogel were significantly
higher than those for the other formulations; these differences
were reflected in the partition parameter (KL) uniquely, as the
diffusion parameter (D/L2) was insensitive to the formulation
(Table 3).
Comparison between in vitro data (silicone membrane and pig
ear skin) and in vivo (human volunteer) results
Although the results obtained with silicone membranes
certainly differentiate the formulations efficiently (and
much more so than skin dermatomed from the pig ear), the
flux values obtained are not indicative of those across
the biological tissue (Figure 4). For Artofen, silicone
membrane under-predicts skin flux whereas, for Iprogel and
Brufen, it overpredicts significantly. Only for Optifen are
comparable values observed. It would appear, therefore, that
silicone membrane cannot be considered as a representative
model of the skin in that it is unable to reflect the complex
interactions between the skin and excipients of
the formulation, the properties of which, furthermore, may
be significantly modified by back diffusion of water from the
receptor compartment.
Although transport through silicone membranes remains
useful to differentiate the relative permeabilities of diverse
compounds being delivered from aqueous solution (where
the problem of back diffusion of the solvent is moot), this
synthetic barrier may not be expected to be a useful tool for
vehicle screening and optimization.
Ibuprofen steady-state fluxes estimated across human skin
in vivo (Table 1) agreed reasonably well with those measured
in vitro through dermatomed pig ear skin (Figure 5),
consistent with other findings that have supported the validity
of the animal model (Moser et al., 2001). A one-way analysis
Table 2. Transport parameters of ibuprofen across silicone membrane from four gels (mean7SD, n=4)
Formulation Jss (lg cm
2 h1)1,2 104Kp (cm h1)2,3 102Ksilicone/vehicle2,4 D/L2 (h1)5,6
ARTOFEN 7.570.95 0.7570.095 0.4470.087 1.570.27
BRUFEN 377757 75711 1971.8 3.470.34
IPROGEL 580761 116712 13.870.43 7.070.22
OPTIFEN 1471.6 2.970.32 1.0770.037 2.2270.075
ANOVA, analysis of variance; SD, standard deviation.
1Values obtained from linear regression of the cumulative amount permeated versus time profiles.
2One-way ANOVA indicates that all values are statistically different (Po0.05) except those of Artofen and Optifen.
3Kp=Jss/Cv.
4Ksilicone/vehicle was determined experimentally.
5D/L2=Kp/(LKsilicone/vehicle).
6One-way ANOVA reveals that all formulations have significantly (Po0.05) different diffusivity parameters.
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Figure 3. Ibuprofen transport across excised porcine skin in vitro.
Cumulative permeation of ibuprofen from four gels through dermatomed pig
ear skin (mean7SD, n¼ 7–9).
Table 3. Transport parameters of ibuprofen through
dermatomed pig ear skin from four gels (mean7SD,
n=7–9)
Formulation
103Kp1,2
(cm/h)
Jss
2,3
(lg cm2 h1)
103KL2,4
(cm)
D/L2
4; 5
(h1)
ARTOFEN 0.2570.10 25710 3.271.3 0.0870.025
BRUFEN 1.6070.71 80735 15.875.3 0.1070.026
IPROGEL 1.2270.27 61713 12.272.2 0.1070.015
OPTIFEN 0.3670.16 1878 3.872.1 0.1070.028
ANOVA, analysis of variance; SD, standard deviation.
1The permeability coefficient, Kp=KL(D/L
2); KL and D/L2 were from the
fitting procedure.
2One-way ANOVA indicates that values from Brufen and Iprogel were
significantly higher (Po0.05) than those from Artofen and Optifen.
3Jss=KpCv.
4Values deduced by fitting the observed ibuprofen permeation versus time
profiles to Eq. (3).
5One-way ANOVA indicates no significantly difference (P40.05)
between these values.
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of variance showed that the in vivo and in vitro results for
Artofen and Optifen were statistically indistinguishable,
whereas the former were about half of the latter for Brufen
and Iprogel.
Examination of the diffusion and partitioning parameters
sheds some light on these results. The calculated values of
D/L2 are similar in vivo and in vitro (Figure 6), with no
significant differences for the values of Artofen and Optifen.
In contrast, those for Brufen and Iprogel are different, but in
the opposite sense to the steady-state flux values (i.e., the
D/L2 in vivo is greater than that determined in vitro; analysis
of variance, Po0.05). In practice, this would mean that the
in vitro experiment would predict a significantly longer lag
time, and a longer time to achieve steady-state diffusion, for
these formulations (B5 hours versus 2 hours). It is encoura-
ging, nevertheless, that the absolute values are very close to
one another and that the values range only over a factor of 2.
To compare the in vivo and in vitro SC–vehicle partition
coefficients, the in vitro partitioning parameter (KL) must first
be divided by a suitable value of L. Although transport in
this case occurred through a piece of dermatomed skin
ofB750mm thickness, it is clearly more appropriate to use an
average value of L equal to the SC thickness as this layer of
the skin is the rate-limiting barrier. Based on other experi-
ments (Herkenne et al., 2006), the in vitro partitioning
parameters were therefore converted to SC–vehicle partition
coefficients using L¼10 mm. The in vitro–in vivo comparison
is shown in Figure 7. It is first of all reassuring to note that
conversion of the in vitro KL values yields partition
coefficients that are very close, in absolute terms, to those
obtained in vivo. Once more, the values for Artofen
and Optifen are indistinguishable in vitro from in vivo. In
contrast, the in vitro K values deduced for Brufen and Iprogel
are significantly higher (by about a factor of 4) than those
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Figure 4. Relative fluxes of drug across silicone and porcine skin membranes
in vitro. Comparison of the average (n¼4–9) in vitro steady-state fluxes
of ibuprofen from various formulations across silicone membrane and
dermatomed pig ear skin.
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Figure 5. Ibuprofen fluxes across porcine (in vitro) and human (in vivo) skin.
In vivo (open bars)–in vitro (hatched bars) comparison of the steady-state flux
(mean7SD, n¼ 4–9).
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Figure 6. Ibuprofen diffusivity parameters through porcine (in vitro) and
human (in vivo) skin. In vivo (open bars)–in vitro (hatched bars) comparison
of the deduced diffusion parameter (mean7SD, n¼4–9).
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Figure 7. Ibuprofen partition coefficients into porcine (in vitro) and human
(in vivo) skin. In vivo (open bars)–in vitro (hatched bars) comparison of the
deduced K values (mean7SD, n¼ 4–9).
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in vivo, accounting for the observed differences in steady-
state flux discussed above. That is, the 2-fold higher fluxes
for these formulations is the result of the combined effects
of a 4-fold increase in K modulated by a 50% lower diffusivity
in the SC.
CONCLUSION
This study has provided a detailed evaluation in vitro (in two-
model systems) and in vivo of four topical products that are
nominally expected to provide comparable delivery of the
same therapeutic agent. The differences in performance
determined in vivo using the SC tape-stripping technique to
assess local bioavailability were not reproduced by in vitro
experiments, which determined drug transport across silastic
membranes. More conventional in vitro studies using freshly
excised skin from pig ears were more predictive of in vivo
behavior, but some significant differences were observed.
Attention should be paid, therefore, to the extrapolation of in
vitro findings to the clinical situation, especially when complex
interactions between real formulations, which deliver not only
the drug but also an array of excipients, and the skin occur.
Furthermore, with respect to clinical relevance, it should
be emphasized that the results of the study described here
now need to be confirmed in more relevant ‘‘in-use’’
scenarios. In particular, the essentially ‘‘infinite’’ doses used
must be replaced by the finite amounts that are typically
applied to patients. In addition, the usefulness of in vitro
porcine skin as a model to predict in vivo absorption in man
needs to be extended to other drugs of diverse physicochem-
ical properties delivered from representative pharmaceutical
formulations. Only in this way can convincing validation of
the methods and models presented be achieved.
MATERIALS AND METHODS
Chemicals
The gels examined were Artofen (10% w/w ibuprofen) from
Democal (Bern, Switzerland), Brufen (5% w/w ibuprofen) from
Knoll (Liestal, Switzerland), Iprogel (5% w/w ibuprofen) from Mepha
Pharma (Aesch, Switzerland), and Optifen (5% w/w ibuprofen) from
Spirig (Egerkingen, Switzerland). Brufen and Iprogel both contain
propylene glycol, and the former (according to the information
provided to the consumer with the product) also contains
isopropanol. More specific information about the composition of
the gels is not available. Solvents used for ibuprofen extraction and
liquid chromatographic (HPLC) analysis were HPLC grade (Sigma-
Aldrich, Steinheim, Germany). Citric acid monohydrate, sodium
hydroxide (Sigma-Aldrich, Steinheim, Germany), and hydrochloric
acid (Fluka, Buchs, Switzerland) were used in buffer preparation.
In vivo experiments
Experimental procedure. Four volunteers (one female, three
male, 29–58 years) with no history of dermatological disease
participated in this study, which was approved by the University
of Geneva ethical committee in adherence with the Declaration of
Helsinki Principles. Informed consent was obtained from all subjects.
The treated sites (4 5 cm) were non-hairy regions of the ventral
forearm surface. Each treatment involved application of 1 g of
ibuprofen gel, which was then covered by an occlusive polyester layer
(Scotchpak, 3 M, St Louis, MN), and affixed to the skin with an adhesive
polyurethane film (Opsite, SmithNephew, Hull, UK). This application
could be considered as an infinite dose from which negligible drug
depletion was anticipated during the experiment. After 30 minutes of
contact, the patch was removed and excess formulation was gently
removed using three dry cellulose swabs without any solvent.
SC sampling protocol. The ibuprofen concentration profile across
the SC following application in the different vehicles was determined
by sequential removal of the outer skin layer by tape-stripping
(Scotch Book Tape, 3 M, St Louis, MN). The SC sampling site was
delimited by a template, which exposed an area smaller than that
treated with the formulation. The template was centered over the
drug application site immediately before tape-stripping began. The
size of the opening in the template (2 2.5 cm2) was smaller than
the individual tape-strips used. Differential weighing (Mettler AT 261
balance, Greifensee, Switzerland) of tape-strips allowed the amount
of SC removed to be estimated. From this mass, and knowing
the area of the tape, it was possible to calculate the SC thickness
removed (using an SC density of 1 g/cm3 (Anderson and Cassidy,
1973) as a function of stripping and hence the corresponding
position (or depth, x) within the barrier. The apparent SC thickness
(L) was determined as described elsewhere (Kalia et al., 2001) from
measurements of TEWL as a function of SC removed. This permits
the drug concentration profile to be expressed as a normalized
function of relative position within the SC (x/L) and facilitates
the comparison of data originating from different volunteers (Alberti
et al., 2001a, b; Kalia et al., 2001). Briefly, as the SC is progressively
removed by tape-stripping, TEWL increases from the baseline value
to a level indicative of skin with no intact barrier (on the order of
100 g m2 h1). Because the physical nature of the barrier is uniform
across its thickness (Kalia et al., 1996), the change in TEWL is slow at
first, becoming increasingly more significant as more and more
layers of SC are removed. Simple application of Fick’s first law of
diffusion to the passive loss of water across the progressively
deranged barrier yields a linear relationship between (TEWL)1
and the thickness (x) of SC removed: (TEWL)1¼ [Lx]/KD (where
D is the diffusivity of water in the SC and K is its SC–water partition
coefficient). Plotting (TEWL)1 versus x gives a straight line, with a
negative slope that intercepts the x-axis at x¼ L, the SC thickness.
The TEWL measurements were made at a site adjacent to
the treated skin. This was because (a) volatile solvents from the
formulation can perturb the evaporimeter, resulting in artificially
high TEWL readings (data not shown), and (b) each TEWL
measurement requires at least 2 minutes during which the drug
continues to diffuse into the SC, and modifies the concentration
profile. A total of 10–12 strips were taken from each treated site on
each volunteer, the actual number depending upon the individual’s
SC thickness; however, the SC was never completely removed. All
tapes were subsequently analyzed for ibuprofen; no strips were
discarded, and it was assumed that any drug not removed by the
surface cleaning process at the end of the treatment would
eventually be bioavailable to the skin.
Extraction and analysis of ibuprofen in the tape strips
After re-weighing, the tape-strips were rolled and placed in a 1.5 ml
HPLC vial. Ibuprofen was quantitatively extracted with a 90:10
mixture of acetonitrile and 1 M hydrochloric acid during 12 hours.
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Validation of this procedure was evaluated by spiking tape-stripped
samples of untreated SC with known amounts of drug in solution,
chosen to bracket the expected range of concentrations to be
found in the in vivo samples. It was not necessary to filter the tape-
strip extraction solution, which were completely clear and protein-
free (Biorad protein assay, Hercules, CA). Ibuprofen was analyzed by
HPLC using a Merck Lichrospher 100 RP18 (5 mm) column
(Darmstadt, Germany) and a model 486 absorbance detector from
Waters (Milford, MA) at 227 nm. The isocratic mobile phase was a
55:45 (v/v) mixture of acetonitrile and 0.1 M citrate buffer at pH 2.4.
At a flow rate of 1.2 ml/min, and at room temperature, the retention
time of ibuprofen was about 5 minutes. Peak recording and data
processing were performed with the built-in system manager.
Ibuprofen was determined using the area under the curve method
and calibration plots were generated with the neat compound. The
quantification limit was 0.5 mg/ml.
Experimental strategy and data analysis
The SC concentration (Cx) versus normalized depth (x/L) profiles of
ibuprofen were fitted to the following solution of Fick’s second law
of diffusion:
Cx ¼ KCv 1 x
L
 

n 2
p
X1
n¼1
1
n
sin
npx
L
 
exp
Dn2p2t
L2
 
ð1Þ
The applicable boundary conditions are as follows: (i) the applied
drug concentration (Cv) remains constant during the treatment period
(t); (ii) the viable epidermis acts as a perfect sink for the drug; and (iii)
the SC contains no drug at t¼ 0. The fitting generates values of K and
D/L2. The former is the SC/vehicle partition coefficient, a thermo-
dynamic parameter reflecting the relative affinity of the drug for the
SC over the vehicle. The second parameter has units of (time)1 and
can be considered as a first-order kinetic constant describing drug
diffusion across the SC. Integration of Eq. (1) across the SC thickness
(i.e., from x/L¼ 0 to x/L¼ 1) provides an expression for the area
under the SC concentration versus relative depth profile (area under
the curve), which equals the total amount of drug present in the
membrane divided by volume of this compartment:
AUC ¼
Z1
0
Cxdðx=LÞ
¼K :Cv 1
2
 4
p2
X1
n¼0
1
ð2n þ 1Þ2 exp 
ð2n þ 1Þ2:p2:D:t
L2
 !( ) ð2Þ
In vitro experiments
The permeation of ibuprofen through both silicone membrane and
pig ear skin was determined using vertical diffusion cells. The
exposed membrane surface area was B2 cm2 and the receptor
volume was about 6.5 ml (of course, both values for each cell were
determined accurately). The receptor medium was phosphate-
buffered saline (67 mM) at pH 7.4, stirred at 500 r.p.m. and
maintained at 371C. The membranes were not equilibrated with
water or buffer solution, to avoid any hydration-induced modifica-
tions and to mimic as closely as possible the in vivo situation.
Artofen and Optifen are less viscous formulations than Brufen
and Iprogel for which care was taken to ensure good contact
between the gels and the model membranes. At different times up to
8 hours, 200 ml of receptor medium were removed and replaced
with 200 ml of fresh solution. The cumulative amount of permeated
drug from each formulation was analyzed by HPLC as before and
plotted as a function of time. The pH of the phosphate-buffered
saline changed only slightly during the course of the experiment
(less than 0.1 of a pH unit).
Silicone membrane
The steady-state flux (J) (i.e., the slope of the graph of cumulative
amount permeated versus time) of ibuprofen from the gels was
determined across silicone membranes (Silatos, 120mm thickness
from Atos Medical (Ho¨rby, Sweden)). Partitioning of the drug
between the silicone membrane and each gel was measured
by equilibrating them together in a hermetic cup at 201C (Figure 8).
A glass slide covered the formulation to prevent solvent
evaporation. After 48 hours, the membrane was recovered and
any excess material was removed from the surface by gentle
rubbing with a cotton swab. Ibuprofen was quantitatively
extracted from the membrane with a 90:10 mixture of acetonitrile
and 1 M HCl during 12 hours. Validation of this procedure
was obtained by spiking untreated silicone membrane with a
known amount of drug in ethanol solution. The ratio of J to the
drug concentration of the gel yielded the drug’s permeability
coefficient (Kp) through the membrane. From Kp, the known
thickness of the membrane, and the experimentally determined
partition coefficient (K), the ibuprofen diffusivity (D¼KpL/K) through
the membrane was deduced.
Dermatomed pig ear skin
Fresh pig ears (n¼ 7–9) were supplied from a local abattoir
(SODEXA, Annecy, France). After washing with water, skin was
dermatomed at 750mm (Zimmer air dermatome, Dover, Delaware).
These membranes were stored until used at 201C for no longer than
1 month. Before use, the skin was allowed to thaw for 30 minutes.
Approximately 1 g of gel was deposited in the donor compartment of
the diffusion cell, and the cumulative amount permeating to the
receptor as a function of time (Q(t)) was fitted to the following
solution of Fick’s second law of diffusion (with n¼ 10):
QðtÞ ¼ ðKLÞCv D
L2
t  1
6
 2
p2
X1
n¼1
ð1Þn
n2
exp n2p2 D
L2
t
 " #
ð3Þ
to yield values of KL and D/L2, where L is the thickness of the skin
barrier; the parameters of KL and D/L2 reflect, respectively, the
partitioning and diffusivity behavior of the drug.
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Figure 8. Device for determination of silicone membrane – gel partition
coefficients. Determination of the silicone–gel partition coefficient.
Membranes were equilibrated with each gel (n¼3) for 48 hours.
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